Michael B. Sporn

Dartmouth College — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

151h-index91.2kcitations679works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

TGF-β signaling in diseases(117), Retinoids in leukemia and cellular processes(86), Genomics, phytochemicals, and oxidative stress(79), Estrogen and related hormone effects(72), Natural product bioactivities and synthesis(53)

Publications679 total

The synthetic oleanane triterpenoid <scp>CDDO‐2P‐Im</scp> binds <scp>GRP78</scp>/<scp>BiP</scp> to induce unfolded protein response‐mediated apoptosis in myeloma
Molecular Oncology·2023· 6 citedOpen Access
Figure S5 from Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762
2023Open Access
Figure S3 from Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762
2023Open Access
Figure S1B from Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762
2023Open Access
Figure S6 from Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762
2023Open Access
Data from The Synthetic Triterpenoid CDDO-Methyl Ester Delays Estrogen Receptor–Negative Mammary Carcinogenesis in Polyoma Middle T Mice
2023Open Access
Figure S3 from Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762
2023Open Access
Figure S5 from Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762
2023Open Access
Supplementary Data from Testing Novel Pyrimidinyl Rexinoids: A New Paradigm for Evaluating Rexinoids for Cancer Prevention
2023Open Access
Fig S2A from Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762
2023Open Access
Figure S1A from Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762
2023Open Access
Figure S2B from Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762
2023Open Access
Figure S7 from Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762
2023Open Access
Suppl Fig legends from Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762
2023Open Access
Data from Testing Novel Pyrimidinyl Rexinoids: A New Paradigm for Evaluating Rexinoids for Cancer Prevention
2023Open Access
Data from Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
2023Open Access
Supplemental Data from The Rexinoids LG100268 and LG101506 Inhibit Inflammation and Suppress Lung Carcinogenesis in A/J Mice
2023Open Access
Perspective on This Article from Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer
2023Open Access
Supplementary Data from Testing Novel Pyrimidinyl Rexinoids: A New Paradigm for Evaluating Rexinoids for Cancer Prevention
2023Open Access
Figure S1A from Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762
2023Open Access
page 1 of 34Next →

Frequent Co-authors

Anita B. Roberts(28), Lalage M. Wakefield(11), N S Roche(6), Kathleen C. Flanders(6), Richard K. Assoian(5), Joseph M. Smith(3), Ursula Heine(3), John H. Kehrl(3), Karen T. Liby(3), David M. Smith(3), Andrew G. Geiser(2), Alistair B. Roberts(2), George J. Todaro(2), Benoît De Crombrugghe(2), Mario A. Anzano(2), Lois C. Lamb(2), A S Fauci(2), Paturu Kondaiah(2), Tohru Masui(2), Curtis C. Harris(2)